间皮素作为癌症免疫治疗的生物标志物和治疗靶点
Mesothelin as Biomarker and Therapeutic Target for Immunotherapy in Cancer.
癌症仍是一个关键的全球健康问题,原因在于发现晚、耐药和高死亡率。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Prognostic Effect of Tertiary Lymphoid Structures in Epstein-Barr Virus-Associated Gastric Carcinomas Measured by Digital Image Analysis.
Prognostic Effect of Tertiary Lymphoid Structures in Epstein-Barr Virus-Associated Gastric Carcinomas Measured by Digital Image Analysis.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
EB 病毒相关胃癌(EBVaGC)以TIL(肿瘤浸润淋巴细胞)显著为特征,且预后较好。三级淋巴结构(TLS)由异位聚集的淋巴细胞及高内皮微静脉(HEV)构成,与多种实体瘤的良好结局相关。研究者据此假设,TIL 丰富的 EBVaGC 可能与 TLS 或 HEV 密切相关。为验证该假设,研究对 73 例手术切除的晚期 EBVaGC 进行 TLS、HEV 和 TIL 数字化分析。HEV 采用 MECA-79 和 CD31 双重免疫组化染色,并测量肿瘤细胞中异位 MECA-79 表达。73 例 EBVaGC 患者中,29 例(39.7%)TLS 比率高,44 例(60.3%)肿瘤相关 HEV 密度高,38 例(52.1%)CD8+ TIL 密度高。36 例(49.3%)观察到肿瘤异位表达 MECA-79。TLS 比率低和肿瘤相关 HEV 密度低均与淋巴结转移显著相关(P 分别为 0.005 和 0.042)。肿瘤异位表达 MECA-79 也与淋巴结转移显著相关(P=0.003)。TLS 比率低(P=0.038)、HEV 密度低(P=0.042)及肿瘤异位表达 MECA-79(P=0.032)的患者预后显著较差。
总之,TLS 比率和 HEV 密度影响 EBVaGC 患者生存,可能与阻断淋巴结转移的免疫应答有关。
Epstein-Barr virus-associated gastric carcinoma (EBVaGC) is characterized by prominent tumor-infiltrating lymphocytes (TILs) and has a favorable prognosis. Tertiary lymphoid structures (TLS), characterized by ectopic aggregated lymphocytes with high-endothelial venules (HEV), are associated with favorable outcomes in various solid tumors.
We hypothesized that EBVaGC, characterized by intense TILs, may be closely associated with TLS or HEV. To test this hypothesis, we digitally analyzed the TLS, HEV, and TILs in 73 surgically resected advanced EBVaGCs. For HEV, dual MECA-79 and CD31 dual immunohistochemistry were performed, and the ectopic expression of MECA-79 in tumor cells was measured. In 73 patients with EBVaGC, a high-TLS ratio was found in 29 (39. 7%) cases, high-tumor-associated HEV density in 44 (60. 3%) cases, and high-CD8 + TIL density in 38 (52.
1%) cases. Ectopic tumor expression of MECA-79 was observed in 36 patients (49. 3%) cases. A low-TLS ratio and tumor-associated HEV density were significantly associated with lymph node metastasis (P = . 005 and . 042, respectively). Ectopic MECA-79 expression was significantly associated with lymph node metastasis (P = . 003). Patients with a low-TLS ratio (P = . 038), low-HEV density (P = . 042), and ectopic tumor MECA-79 expression (P = . 032) had significantly worse prognoses.
In conclusion, TLS ratio and HEV density affect the survival of patients with EBVaGC and may be related to the immune response that interrupts lymph node metastasis.
MEMBER ACCOUNT
登录成功会直接打开下一页。